However, the overall inhibitory effects of 17-AAG on bulk tumor growth were comparable in the BAX+/− and BAX−/− HCT116 colon cancer models, indicating that apoptosis induction is not limiting in the in vivo solid tumor setting and that antiproliferative effects likely dominate the therapeutic response. This evidence concerns the gene BAX and malignant colon neoplasm.